title: Cystic Brain Metastases in NSCLC Harboring the EML4-ALK Translocation after Treatment with Crizotinib.
authors.affiliation: *Lehigh Valley Health Network, Allentown, PA; †Massachusetts General Hospital, Boston, MA; and ‡Health Network Laboratories, Lehigh Valley Health Network, Allentown, PA.
authors.forename: Christine
authors.initials: C
authors.lastname: Saraceni
authors.forename: P Mark
authors.initials: PM
authors.lastname: Li
authors.forename: Justin F
authors.initials: JF
authors.lastname: Gainor
authors.forename: Gary A
authors.initials: GA
authors.lastname: Stopyra
authors.forename: Eliot L
authors.initials: EL
authors.lastname: Friedman
mesh_terms: D000328:Adult; D000077548:Anaplastic Lymphoma Kinase; D001932:Brain Neoplasms / Q000201:enzymology / Q000235:genetics / Q000556:secondary*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D018797:Cell Cycle Proteins / Q000235:genetics* / Q000378:metabolism; D000077547:Crizotinib; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000473:pathology; D008869:Microtubule-Associated Proteins / Q000235:genetics* / Q000378:metabolism; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics* / Q000378:metabolism; D012697:Serine Endopeptidases / Q000235:genetics* / Q000378:metabolism; D014178:Translocation, Genetic
chemical_list: D018797:Cell Cycle Proteins; D008869:Microtubule-Associated Proteins; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011725:Pyridines; D000077547:Crizotinib; C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D020794:Receptor Protein-Tyrosine Kinases; C415585:EML4 protein, human; D012697:Serine Endopeptidases